GB202218958D0 - New pharmaceutical composition - Google Patents
New pharmaceutical compositionInfo
- Publication number
- GB202218958D0 GB202218958D0 GBGB2218958.3A GB202218958A GB202218958D0 GB 202218958 D0 GB202218958 D0 GB 202218958D0 GB 202218958 A GB202218958 A GB 202218958A GB 202218958 D0 GB202218958 D0 GB 202218958D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- new pharmaceutical
- new
- composition
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2218958.3A GB202218958D0 (en) | 2022-12-15 | 2022-12-15 | New pharmaceutical composition |
| PCT/GB2023/053231 WO2024127018A1 (en) | 2022-12-15 | 2023-12-14 | New injectable suspension of coated particles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2218958.3A GB202218958D0 (en) | 2022-12-15 | 2022-12-15 | New pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202218958D0 true GB202218958D0 (en) | 2023-02-01 |
Family
ID=85035717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2218958.3A Ceased GB202218958D0 (en) | 2022-12-15 | 2022-12-15 | New pharmaceutical composition |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202218958D0 (en) |
| WO (1) | WO2024127018A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006080895A1 (en) | 2005-01-20 | 2006-08-03 | Agency For Science, Technology And Research | Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling |
| ES2922465T3 (en) | 2013-05-24 | 2022-09-15 | Nanexa Ab | Preparation method of solid nanoparticles with an inorganic coating and use thereof |
| CA3163510A1 (en) * | 2019-12-06 | 2021-06-10 | Nanexa Ab | New composition |
| GB202005593D0 (en) | 2020-04-17 | 2020-06-03 | Nanexa Ab | New composition |
-
2022
- 2022-12-15 GB GBGB2218958.3A patent/GB202218958D0/en not_active Ceased
-
2023
- 2023-12-14 WO PCT/GB2023/053231 patent/WO2024127018A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024127018A1 (en) | 2024-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202019241D0 (en) | Pharmaceutical composition | |
| IL304290A (en) | Pharmaceutical composition | |
| IL314046A (en) | Ribociclib pharmaceutical compositions | |
| GB202208464D0 (en) | Pharmaceutical composition | |
| GB202104224D0 (en) | Pharmaceutical composition | |
| GB202018068D0 (en) | Pharmaceutical composition | |
| GB202010340D0 (en) | Pharmaceutical composition | |
| GB202218958D0 (en) | New pharmaceutical composition | |
| GB202218929D0 (en) | New pharmaceutical composition | |
| GB202213306D0 (en) | New pharmaceutical composition | |
| GB202208144D0 (en) | New pharmaceutical composition | |
| GB202316245D0 (en) | Rapamycin-containing pharmaceutical composition | |
| GB202117005D0 (en) | New pharmaceutical composition | |
| GB202117007D0 (en) | New pharmaceutical composition | |
| GB202117015D0 (en) | New pharmaceutical composition | |
| GB202217146D0 (en) | New pharmaceutical compositions | |
| GB202217150D0 (en) | New pharmaceutical compositions | |
| GB202018901D0 (en) | New pharmaceutical composition | |
| GB202009905D0 (en) | New pharmaceutical composition | |
| GB202007306D0 (en) | New pharmaceutical composition | |
| GB202007328D0 (en) | New pharmaceutical composition | |
| IL324773A (en) | Pharmaceutical compositions | |
| IL320961A (en) | Milvexian pharmaceutical compositions | |
| GB202109271D0 (en) | Pharmaceutical composition | |
| GB202108387D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |